Targeted Intervention for Bipolar Smokers
All participants will receive the nicotine patch, an FDA-approved smoking cessation
medication, in an open-label fashion. In addition to the nicotine patch, participants will
be randomized to receive one of the two types of counseling for smoking cessation.
Participants will be in the research study for approximately 18 weeks. The total number of
study visits is 15.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Prolonged Abstinence from Smoking
Confirmed prolonged abstinence from smoking during the last 4 weeks of the treatment period.
Last four weeks of treatment period
Jaimee Heffner, MD
University of Cincinnati
United States: Institutional Review Board
|The University of Cincinnati||Cincinnati, Ohio 452219|